期刊文献+

生物素化胆甾醇基普鲁兰糖合成及其自聚集性质 被引量:2

Synthesis of biotin modified cholesteryl pullulan and its self-aggregated behavior
下载PDF
导出
摘要 通过酯化反应将生物素接枝于胆甾醇基普鲁兰糖链上,获得不同取代度的生物素化胆甾醇基普鲁兰糖(Bio-CHSP)衍生物.采用氢核磁(1 H NMR)和X线粉末衍射法(XRD)共同验证Bio-CHSP材料的成功合成,并用1 H NMR法确定Bio-CHSP的生物素取代度.Bio-CHSP改性材料具有两亲性,透射电镜(TEM)显示,可在水中自聚集成球型纳米粒.动态激光粒度分析仪(DLS)测定表明,Bio-CHSP纳米粒带负电荷且粒径随生物素取代度增大而减小.以芘为荧光探针,采用稳态荧光法测定Bio-CHSP纳米粒水溶液的临界聚集浓度(CAC),其CAC随生物素取代度的增大而减小.Bio-CHSP材料在水中表现出良好的自聚集特性,有望成为一种新型抗肿瘤药物的纳米载体. The biotin modified cholesteryl pullulan (Bio-CHSP) was prepared by the esterification reaction of biotin and cholesteryl pullulan (CHSP) in DMSO. The structure of Bio-CHSP was confirmed by the X- ray diffraction (XRD) and proton nuclear magnetic resonance (1 H NMR), and the degree of substitution (DS) of biotin moiety was determined by 1H NMR. Bio-CHSP self-aggregated nanoparticles (Bio-CHSP NPs) were prepared by the dialysis method, analyzed by dynamic light-scattering (DLS), zeta potential, transmission electron microscopy(TEM) and their self-aggregated behavior in aqueous solution were evalu- ated by fluorescence probe technologies. The results of the experiment showed that Bio-CHSP with differ- ent DS of biotin moieties was successfully synthesized and the polymer could self-aggregate to form spheri- cal nanoparticles. The zeta potential was negative, their sizes and critical aggregation concentration (CAC) were decreased with the increasing of DS. Bio-CHSP polymer showed a good self-aggregation behavior in water, therefore, Bio-CHSP was a promising potential as a novel nanometer carrier for antitumor drugs.
机构地区 河北大学药学院
出处 《河北大学学报(自然科学版)》 CAS 北大核心 2014年第1期34-39,共6页 Journal of Hebei University(Natural Science Edition)
基金 河北省自然科学基金资助项目(H2012201069) 河北省科技计划项目(13272705) 河北大学博士基金资助项目(2010-193)
关键词 生物素 生物素化胆甾醇基普鲁兰糖 自聚集纳米粒 biotin biotin modified cholesteryl pullulan self-aggregated nanoparticles
  • 相关文献

参考文献18

  • 1JENOG Y I,NA H S,OH J S,et al. Adriamycin release from self-assembling nanospheres of poly(dl-lactide-co-glycolide)- grafted pullulan[J]. International Journal of Pharmaceutics,2006,322(1 - 2) :154 - 160.
  • 2FUNDUEANU G, CONSTANTIN M, ASCENZI P. Preparation and characterization of pH-and temperature-sensitive pullulan microspheres for controlled release of drugs[J]. Biomaterials, 2008,29 (18) : 2767 - 2775.
  • 3SIVAKUMAR P A,PANDURANGA R K. The use of cholesteryl pullulan for the preparation of stable vincristine lipo- somes[J]. Carbohydrate Polymers, 2003,51 (3) : 327 - 332.
  • 4LEATHERS T D. Biotechnological production and applications of pullulan[J]. Appl Microbiol Biotechnol, 2003,62 (5 - 6) :468- 473.
  • 5FISCHER S, UETZ-VON ALLMEN E,WAECKERLE-MEN Y, et al. The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles [J]. Biomaterials, 2007,28 (6) : 994 - 1004.
  • 6ZHANG H uizhu, GAO Fuping, LIU Lirong, et al. Pullulan acetate nanoparticles prepared by solvent diffusion method for epirubicin chemotherapy[J]. Colloids and Surfaces B: Biointerfaces, 2009,71(1):19- 26.
  • 7JUNG S W,JEONG Y I, KIM Y H,et al. Self-assembled polymeric nanoparticles of poly(ethylene glycol) grafted pullu- lan acetate as a novel drug carrier[J]. Arch Pharm Res, 2004,27(5) :562 - 569.
  • 8HIRAKURA T, YASUGI K,AKIYOSHI K,et al. Hybrid hyaluronan hydrogel encapsulating nanogel as a protein nano- carrier: New system for sustained delivery of protein with a chaperone-like function[J]. Journal of Controlled Release, 2010,142(3): 483 - 489.
  • 9SUNAMOTO J,USHIO K, LAI DT. Folate-modified cholesterol-bearing pullulan, a new cancer-targeted nanoparticle drug carrier : synthesis and applications[J]. J Bioact Compat Polym, 2006,21 (6) : 603 - 617.
  • 10TAO Xiaojun,ZHANG Qiufang,LING Kai, et al. Effect of pullulan nanoparticle surface charges on HSA complexation and drug release behavior of HSA-bound nanoparticles[J]. PLOS ONE, 2012,7 (11) : e49304.

同被引文献7

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部